Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study

Journal of Hypertension
Francisco Javier Félix-RedondoVivencio Barrios

Abstract

To determine the prevalence of left-ventricular hypertrophy (LVH) in the general population by means of multiple electrocardiographic criteria and those variables independently associated. Random-sample cross-sectional study of the general population aged between 25 and 79 years, representative of a health area, was conducted. An electrocardiogram was recorded 'on line' in the Electropres project website; 17 LVH criteria together with two combined criteria were used. By multivariate analysis we examined those variables independently associated with the presence of electrocardiographic LVH. We recruited 2564 individuals, mean age 50.9 [standard deviation (SD) 14.7] years, 45.7% men. The criteria more prevalent were: Dalfó 19.4%, RV6/V5 14.5%, Perugia 10.9%, any combination with at least three positive criteria (Combined 3) 9.4%, Romhilt 7.5%, Lewis 6.2% and the recommended criteria of the European Society of Hypertension 4%. The best prevalence ratio between hypertensive and normotensive individuals was achieved with Lewis, Dalfó and Perugia criteria. The least prevalence was Sokolow 0.7%. The variables that were independently associated with the presence of LVH by Combined 3 criterion were pulse pressure at least 50 [odds ratio...Continue Reading

References

Oct 1, 1994·The American Journal of Cardiology·G SchillaciC Porcellati
Mar 7, 2001·American Heart Journal·B A VakiliR B Devereux
Aug 25, 2004·Hypertension·Robert H FagardUNKNOWN Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
Nov 18, 2004·JAMA : the Journal of the American Medical Association·Peter M OkinUNKNOWN LIFE Study Investigators
Nov 18, 2004·JAMA : the Journal of the American Medical Association·Richard B DevereuxBjörn Dahlöf
Aug 9, 2005·American Heart Journal·Bill P HsiehVictor F Froelicher
Dec 18, 2007·Revista española de cardiología·Vicente BertomeuUNKNOWN VIIDA Study Researchers
Mar 7, 2008·European Journal of Epidemiology·Edoardo CasigliaAchille C Pessina
Oct 1, 2008·The American Journal of Medicine·Edward P HavranekJohn F Steiner
Nov 19, 2008·Hypertension·Joji IshikawaUNKNOWN Jichi Medical School Cohort Study Investigators Group
May 12, 2009·The Medical Clinics of North America·Javier Díez
Apr 20, 2010·Journal of Electrocardiology·Ljuba BacharovaPeter W Macfarlane
May 28, 2010·Clinical and Experimental Hypertension : CHE·Alberto CalderónJosefa Navarro-Cid

❮ Previous
Next ❯

Citations

Nov 6, 2013·American Journal of Hypertension·Manuel A Gómez-MarcosUNKNOWN EVIDENT Study, Spain
May 21, 2015·Clinical and Experimental Hypertension : CHE·Kjestine SchmidtCor de Wit
Nov 7, 2019·The Journal of Clinical Hypertension·Francesca MiceliGiuliano Tocci
Aug 24, 2012·American Journal of Hypertension·Gabriel Coll-de-TueroJoan Bayó-Llibre
Jun 19, 2012·Journal of Hypertension·Athanasios J ManolisLeonidas E Poulimenos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.